NEOBIOMICS is a startup company based in Sweden, and working for the world.
Neobiomics was founded after community-driven discussions about the lack of a bifidobacterial product with high-end manufacturing quality.
Once business is self-propelling and given the roots within academia, Neobiomics will dedicate a fair share of any revenue to research.
AMNION LIFE, a medical device company, was founded to develop the AmnioBed, an amniotic neonatal incubator system that incorporates unparalleled disruptive technology to promote ongoing development immediately following birth.
The mission is to design, patent and market safe and effective medical devices to care for preterm infants.
Visit the web site on http://amnion.life/
MONIVENT is a young medtech company dedicated to improve the emergency ventilatory care given to newborn babies in need of respiratory support at birth. About 3-6 % of all newborns end up in this situation, where healthcare personnel today are lacking tools to determine how effective their manual ventilation really is.
Monivent® Neo, currently under development, helps the caregiver make the necessary adjustments to ensure an effective and gentle ventilation of newborns unable to breathe spontaneously. This monitoring device is an add-on to existing manual ventilation equipment, wirelessly measuring several critical parameters including tidal volume.
MONIVENT recently introduced its first product - Monivent Neo training - used within simulation training on a manikin while a clinical product is currently under development.
Learn more about MONIVENT on: http://monivent.se/
The Strategic Partner NEONATOLOGY TODAY is a monthly newsletter providing timely news and information to health professionals in the Neonatal Perinatal space.
NEONATOLOGY TODAY is a free monthly e-Publication published mid-month.
ABOUT SUPPORTING PARTNERSHIPS
Supporting partners give unrestricted educational grants to 99nicu. Grants are used to cover costs for maintenance, development and technical support of 99nicu. Partnerships are valid per calender year.
Supporting partners are exposed:
- in dedicated announcement in 99nicu.org and in separate email to all members
- by name, URL, logotype and info-text on the Partners page
- by name, URL, and logotype in "partner slider" on the landing page
- by name and URL in the 99nicu newsletters, published on a regular basis (~bi-weekly)
Supporting partners have permission to use the 99nicu logotype, and to communicate in external channels that the organisation/journal/company support 99nicu.
As 99nicu.org is owned by AB EPIKRIS (EU-VAT nb SE556961370501), all grants are invoiced through AB EPIKRIS.
If you are interested to become a Supporting Partner of 99nicu, please email email@example.com